Indiana University

Skip to:

  1. Search
  2. Breadcrumb Navigation
  3. Content
  4. Browse by Topic
  5. Services & Resources
  6. Additional Resources
  7. Multimedia News

Media Contacts

Eric Schoch
eschoch@iupui.edu
317-274-7722

Sherry Knighton-Schwandt
sks@indiana.edu
812-756-0504

Last modified: Thursday, May 3, 2007

Indiana University takes life sciences expertise to Boston for BIO 2007

FOR IMMEDIATE RELEASE
May 3, 2007

BLOOMINGTON, Ind. -- Indiana University's commitment to life sciences will be on display Sunday through Wednesday (May 6-9) in Boston, Mass., when IU participates in BIO 2007, the leading international conference for the biotechnology industry in the United States.

Several of IU's leading entrepreneurial researchers will be on hand to spread the word about the life sciences resources and expertise at the university. Nearly 20,000 biotechnology professionals from around the world are expected to attend BIO 2007.

IU has collaborated with the Indiana Economic Development Corp. and other state life sciences organizations to develop a 1,500-square-foot exhibit to showcase Indiana's life-sciences strengths. In addition to IU, primary sponsors of the Indiana exhibit include Dow AgroSciences and Ivy Tech Community College.

"Indiana University has established a very aggressive set of goals for further expanding its life sciences and technology transfer capacity," said Adam W. Herbert, president of Indiana University. "The Indiana Life Sciences Initiative will bring substantial new life sciences research dollars to the state of Indiana, foster many new spin-off companies and create thousands of new jobs. As our exhibits and presentations at the 2007 BIO conference illustrate, IU undertakes this ambitious long-term plan from a position of significant experience and intellectual strength."

"I am pleased that we have such a strong presence lined up to participate in BIO '07," said Michael A. McRobbie, president-elect of Indiana University. "This is an opportunity for us to again demonstrate our state-wide commitment to greatly expand our life sciences research and teaching enterprises. As we move forward with this plan, it will be increasingly important for our faculty and technology transfer professionals to interact with innovators in biotechnology sciences from around the world and to connect with investors and other potential partners who are interested in making biotechnology an engine for economic growth in Indiana."

"The partnership approach IU is taking in its presence at BIO 2007 demonstrates the university's commitment to collaboration with Life Sciences Initiative," said D. Craig Brater, vice president of IU with responsibility for life sciences and dean of the IU School of Medicine.

"This is an initiative that will have a statewide impact on the economy and Hoosiers' health, and we want to demonstrate our direction to the world," Brater said.

In addition to Brater, faculty representing the university in the exhibit and at conference panel discussions will be:

  • Robert Hickey, associate professor of medicine and researcher at the IU Melvin and Bren Simon Cancer Center.
  • Robert Jones, associate vice president of IU for life sciences and executive associate dean for strategic planning, analysis and operations at the IU School of Medicine.
  • Keith March, director of the Indiana Center for Vascular Biology and Medicine.
  • Eric Meslin, director of the IU Center for Bioethics.
  • David Stocum, director of the IU Center for Regenerative Biology and Medicine.
  • Jeffrey White, associate vice provost for the sciences, IU Office of the Vice Provost for Research.

IU's delegation also will include members from the Indiana University Research and Technology Corporation and the Indiana University Emerging Technologies Center, including Mark Long, president of IURTC.

IU also will be connecting with its Boston-area alumni at a "Hoosier Comeback" luncheon on Monday (May 7), sponsored by IU, Purdue University and the IEDC.

The Biotechnology Industry Organization (BIO) represents more than 1,100 biotechnology companies, state and international affiliates, and related organizations.